Literature DB >> 31780181

Pertussis vaccines: The first hundred years.

Nicole Guiso1, Bruce D Meade2, Carl Heinz Wirsing von König3.   

Abstract

Vaccines against pertussis have been used for more than a hundred years. This review describes the development of whole-cell (wP) and acellular pertussis (aP) vaccines, which, as DTP combination vaccines, have significantly reduced morbidity and mortality from pertussis, and which currently serve as the building blocks for a variety of vaccines used to immunize all infants worldwide. Two series of efficacy trials done in the 1950s for wP vaccines and in the 1990s for aP-vaccines have established standards for studying vaccine effectiveness. However, irrespective of their longtime use, critical aspects of pertussis vaccines remain unknown, including the exact mechanisms of protective immunity and a correlate of protection. Research to improve on the effectiveness and the duration of protection is ongoing, but although the vaccines are not perfect, only their continued use with a high coverage will ensure that infants and children are being protected from pertussis.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Pertussis vaccine whole-cell acellular history

Year:  2019        PMID: 31780181     DOI: 10.1016/j.vaccine.2019.11.022

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Descriptive Overview of Pertussis Epidemiology Among Older Adults in Europe During 2010-2020.

Authors:  Enas Bahar; Daria Shamarina; Yan Sergerie; Piyali Mukherjee
Journal:  Infect Dis Ther       Date:  2022-07-06

Review 2.  Vaccine-Induced Cellular Immunity against Bordetella pertussis: Harnessing Lessons from Animal and Human Studies to Improve Design and Testing of Novel Pertussis Vaccines.

Authors:  Anja Saso; Beate Kampmann; Sophie Roetynck
Journal:  Vaccines (Basel)       Date:  2021-08-07

3.  Characterization of Bordetella pertussis Strains Isolated from India.

Authors:  Shweta Alai; Manish Gautam; Sonali Palkar; Jitendra Oswal; Sunil Gairola; Dhiraj P Dhotre
Journal:  Pathogens       Date:  2022-07-14

Review 4.  Can vaccines control bacterial virulence and pathogenicity? Bordetella pertussis: the advantage of fitness over virulence.

Authors:  Nicole Guiso; Benoit Soubeyrand; Denis Macina
Journal:  Evol Med Public Health       Date:  2022-08-03

5.  Evaluation of the Potency of the Pertussis Vaccine in Experimental Infection Model with Bordetella pertussis: Study of the Case of the Pertussis Vaccine Used in the Expanded Vaccination Program in Algeria.

Authors:  Khedidja Tahar Djebbar; Mounia Allouache; Salim Kezzal; Fouzia Benguerguoura; Chafia TouilBoukoffa; Ines Zidi; Rachida Raache; Hadda-Imene Ouzari
Journal:  Vaccines (Basel)       Date:  2022-06-06

6.  Drought and child vaccination coverage in 22 countries in sub-Saharan Africa: A retrospective analysis of national survey data from 2011 to 2019.

Authors:  Jason M Nagata; Adrienne Epstein; Kyle T Ganson; Tarik Benmarhnia; Sheri D Weiser
Journal:  PLoS Med       Date:  2021-09-28       Impact factor: 11.069

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.